{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T10:10:47Z","timestamp":1790763047750,"version":"4.1.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T00:00:00Z","timestamp":1697068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T00:00:00Z","timestamp":1697068800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Gene Ther"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1038\/s41417-023-00673-4","type":"journal-article","created":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T10:02:34Z","timestamp":1697104954000},"page":"1663-1678","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Exploration of a screening model for intrahepatic cholangiocarcinoma patients prone to cuproptosis and mechanisms of the susceptibility of CD274-knockdown intrahepatic cholangiocarcinoma cells to cuproptosis"],"prefix":"10.1038","volume":"30","author":[{"given":"Zefeng","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwei","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liye","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhao","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengtao","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyu","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yali","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjie","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9423-9201","authenticated-orcid":false,"given":"Xiao","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,12]]},"reference":[{"key":"673_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72:7\u201333. https:\/\/doi.org\/10.3322\/caac.21708.","journal-title":"CA Cancer J Clin"},{"key":"673_CR2","doi-asserted-by":"publisher","first-page":"270","DOI":"10.21037\/hbsn.2018.03.16","volume":"7","author":"EW Beal","year":"2018","unstructured":"Beal EW, Tumin D, Moris D, Zhang XF, Chakedis J, Dilhoff M, et al. Cohort contributions to trends in the incidence and mortality of intrahepatic cholangiocarcinoma. Hepatobiliary Surg Nutr. 2018;7:270\u20136. https:\/\/doi.org\/10.21037\/hbsn.2018.03.16.","journal-title":"Hepatobiliary Surg Nutr"},{"key":"673_CR3","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1001\/jamasurg.2013.5137","volume":"149","author":"MN Mavros","year":"2014","unstructured":"Mavros MN, Economopoulos KP, Alexiou VG, Pawlik TM. Treatment and prognosis for patients with intrahepatic cholangiocarcinoma: systematic review and meta-analysis. JAMA Surg. 2014;149:565\u201374. https:\/\/doi.org\/10.1001\/jamasurg.2013.5137.","journal-title":"JAMA Surg"},{"key":"673_CR4","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1016\/j.jhep.2014.01.021","volume":"60","author":"J Bridgewater","year":"2014","unstructured":"Bridgewater J, Galle PR, Khan SA, Llovet JM, Park JW, Patel T, et al. Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. J Hepatol. 2014;60:1268\u201389. https:\/\/doi.org\/10.1016\/j.jhep.2014.01.021.","journal-title":"J Hepatol"},{"key":"673_CR5","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","volume":"16","author":"JD Yang","year":"2019","unstructured":"Yang JD, Hainaut P, Gores GJ, Amadou A, Plymoth A, Roberts LR. A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat Rev Gastroenterol Hepatol. 2019;16:589\u2013604. https:\/\/doi.org\/10.1038\/s41575-019-0186-y.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"673_CR6","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1002\/hep.29913","volume":"68","author":"JA Marrero","year":"2018","unstructured":"Marrero JA, Kulik LM, Sirlin CB, Zhu AX, Finn RS, Abecassis MM, et al. Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases. Hepatology. 2018;68:723\u201350. https:\/\/doi.org\/10.1002\/hep.29913.","journal-title":"Hepatology"},{"key":"673_CR7","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.1002\/hep.32007","volume":"74","author":"YT Lee","year":"2021","unstructured":"Lee YT, Wang JJ, Luu M, Noureddin M, Nissen NN, Patel TC, et al. Comparison of clinical features and outcomes between intrahepatic cholangiocarcinoma and hepatocellular carcinoma in the United States. Hepatology. 2021;74:2622\u201332. https:\/\/doi.org\/10.1002\/hep.32007.","journal-title":"Hepatology"},{"key":"673_CR8","doi-asserted-by":"publisher","first-page":"639.","DOI":"10.3390\/cancers15030639","volume":"15","author":"L Penzkofer","year":"2023","unstructured":"Penzkofer L, Gr\u00f6ger LK, Hoppe-Lotichius M, Baumgart J, Heinrich S, Mittler J, et al. Mixed hepatocellular cholangiocarcinoma: a comparison of survival between mixed tumors, intrahepatic cholangiocarcinoma and hepatocellular carcinoma from a single center. Cancers (Basel). 2023;15:639. https:\/\/doi.org\/10.3390\/cancers15030639.","journal-title":"Cancers (Basel)"},{"key":"673_CR9","doi-asserted-by":"publisher","first-page":"198","DOI":"10.3322\/caac.21759","volume":"73","author":"D Moris","year":"2023","unstructured":"Moris D, Palta M, Kim C, Allen PJ, Morse MA, Lidsky ME. Advances in the treatment of intrahepatic cholangiocarcinoma: an overview of the current and future therapeutic landscape for clinicians. CA Cancer J Clin. 2023;73:198\u2013222. https:\/\/doi.org\/10.3322\/caac.21759.","journal-title":"CA Cancer J Clin"},{"key":"673_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-015-0321-5","volume":"14","author":"Z Su","year":"2015","unstructured":"Su Z, Yang Z, Xu Y, Chen Y, Yu Q. Apoptosis, autophagy, necroptosis, and cancer metastasis. Mol Cancer. 2015;14:48. https:\/\/doi.org\/10.1186\/s12943-015-0321-5.","journal-title":"Mol Cancer"},{"key":"673_CR11","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","volume":"171","author":"BR Stockwell","year":"2017","unstructured":"Stockwell BR, Friedmann Angeli JP, Bayir H, Bush AI, Conrad M, Dixon SJ, et al. Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease. Cell. 2017;171:273\u201385. https:\/\/doi.org\/10.1016\/j.cell.2017.09.021.","journal-title":"Cell"},{"key":"673_CR12","doi-asserted-by":"publisher","first-page":"110.","DOI":"10.1186\/s13045-020-00946-7","volume":"13","author":"R Tang","year":"2020","unstructured":"Tang R, Xu J, Zhang B, Liu J, Liang C, Hua J, et al. Ferroptosis, necroptosis, and pyroptosis in anticancer immunity. J Hematol Oncol. 2020;13:110. https:\/\/doi.org\/10.1186\/s13045-020-00946-7.","journal-title":"J Hematol Oncol"},{"key":"673_CR13","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1126\/science.abf0529","volume":"375","author":"P Tsvetkov","year":"2022","unstructured":"Tsvetkov P, Coy S, Petrova B, Dreishpoon M, Verma A, Abdusamad M, et al. Copper induces cell death by targeting lipoylated TCA cycle proteins. Science. 2022;375:1254\u201361. https:\/\/doi.org\/10.1126\/science.abf0529.","journal-title":"Science"},{"key":"673_CR14","doi-asserted-by":"publisher","first-page":"R877","DOI":"10.1016\/j.cub.2011.09.040","volume":"21","author":"RA Festa","year":"2011","unstructured":"Festa RA, Thiele DJ. Copper: an essential metal in biology. Curr Biol. 2011;21:R877\u201383. https:\/\/doi.org\/10.1016\/j.cub.2011.09.040.","journal-title":"Curr Biol"},{"key":"673_CR15","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/s41589-019-0291-9","volume":"15","author":"P Tsvetkov","year":"2019","unstructured":"Tsvetkov P, Detappe A, Cai K, Keys HR, Brune Z, Ying W, et al. Mitochondrial metabolism promotes adaptation to proteotoxic stress. Nat Chem Biol. 2019;15:681\u20139. https:\/\/doi.org\/10.1038\/s41589-019-0291-9.","journal-title":"Nat Chem Biol"},{"key":"673_CR16","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.ccell.2021.12.006","volume":"40","author":"L Dong","year":"2022","unstructured":"Dong L, Lu D, Chen R, Lin Y, Zhu H, Zhang Z, et al. Proteogenomic characterization identifies clinically relevant subgroups of intrahepatic cholangiocarcinoma. Cancer Cell. 2022;40:70\u201387. https:\/\/doi.org\/10.1016\/j.ccell.2021.12.006.","journal-title":"Cancer Cell"},{"key":"673_CR17","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1053\/j.gastro.2011.12.005","volume":"142","author":"JB Andersen","year":"2012","unstructured":"Andersen JB, Spee B, Blechacz BR, Avital I, Komuta M, Barbour A, et al. Genomic and genetic characterization of cholangiocarcinoma identifies therapeutic targets for tyrosine kinase inhibitors. Gastroenterology. 2012;142:1021\u201331. https:\/\/doi.org\/10.1053\/j.gastro.2011.12.005.","journal-title":"Gastroenterology"},{"key":"673_CR18","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1002\/hep.31092","volume":"72","author":"S Job","year":"2020","unstructured":"Job S, Rapoud D, Dos Santos A, Gonzalez P, Desterke C, Pascal G. et al. Identification of four immune subtypes characterized by distinct composition and functions of tumor microenvironment in intrahepatic cholangiocarcinoma. Hepatology. 2020;72:965\u201381. https:\/\/doi.org\/10.1002\/hep.31092.","journal-title":"Hepatology"},{"key":"673_CR19","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1016\/j.jhep.2021.06.028","volume":"75","author":"L Ma","year":"2021","unstructured":"Ma L, Wang L, Khatib SA, Chang CW, Heinrich S, Dominguez DA, et al. Single-cell atlas of tumor cell evolution in response to therapy in hepatocellular carcinoma and intrahepatic cholangiocarcinoma. J Hepatol. 2021;75:1397\u2013408. https:\/\/doi.org\/10.1016\/j.jhep.2021.06.028.","journal-title":"J Hepatol"},{"key":"673_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-35291-5","volume":"13","author":"L Ma","year":"2022","unstructured":"Ma L, Heinrich S, Wang L, Keggenhoff FL, Khatib S, Forgues M, et al. Multiregional single-cell dissection of tumor and immune cells reveals stable lock-and-key features in liver cancer. Nat Commun. 2022;13:7533. https:\/\/doi.org\/10.1038\/s41467-022-35291-5.","journal-title":"Nat Commun"},{"key":"673_CR21","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nbt.4096","volume":"36","author":"A Butler","year":"2018","unstructured":"Butler A, Hoffman P, Smibert P, Papalexi E, Satija R. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat Biotechnol. 2018;36:411\u201320. https:\/\/doi.org\/10.1038\/nbt.4096.","journal-title":"Nat Biotechnol"},{"key":"673_CR22","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1093\/bioinformatics\/btq170","volume":"26","author":"MD Wilkerson","year":"2010","unstructured":"Wilkerson MD, Hayes DN. ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking. Bioinformatics. 2010;26:1572\u20133. https:\/\/doi.org\/10.1093\/bioinformatics\/btq170.","journal-title":"Bioinformatics"},{"key":"673_CR23","doi-asserted-by":"publisher","first-page":"174.","DOI":"10.1186\/s13045-022-01392-3","volume":"15","author":"X Tong","year":"2022","unstructured":"Tong X, Tang R, Xiao M, Xu J, Wang W, Zhang B, et al. Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research. J Hematol Oncol. 2022;15:174. https:\/\/doi.org\/10.1186\/s13045-022-01392-3.","journal-title":"J Hematol Oncol"},{"key":"673_CR24","doi-asserted-by":"publisher","unstructured":"Greten TF, Schwabe R, Bardeesy N, Ma L, Goyal L, Kelley RK, Wang XW. Immunology and immunotherapy of cholangiocarcinoma. Nat Rev Gastroenterol Hepatol. 2023. https:\/\/doi.org\/10.1038\/s41575-022-00741-4.","DOI":"10.1038\/s41575-022-00741-4"},{"key":"673_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-016-1070-5","volume":"17","author":"E Becht","year":"2016","unstructured":"Becht E, Giraldo NA, Lacroix L, Buttard B, Elarouci N, Petitprez F, et al. Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression. Genome Biol. 2016;17:218. https:\/\/doi.org\/10.1186\/s13059-016-1070-5.","journal-title":"Genome Biol."},{"key":"673_CR26","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1038\/s41596-020-0292-x","volume":"15","author":"M Efremova","year":"2020","unstructured":"Efremova M, Vento-Tormo M, Teichmann SA, Vento-Tormo R. CellPhoneDB: inferring cell-cell communication from combined expression of multi-subunit ligand-receptor complexes. Nat Protoc. 2020;15:1484\u2013506. https:\/\/doi.org\/10.1038\/s41596-020-0292-x.","journal-title":"Nat Protoc"},{"key":"673_CR27","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/s41586-018-0698-6","volume":"563","author":"R Vento-Tormo","year":"2018","unstructured":"Vento-Tormo R, Efremova M, Botting RA, Turco MY, Vento-Tormo M, Meyer KB, et al. Single-cell reconstruction of the early maternal-fetal interface in humans. Nature. 2018;563:347\u201353. https:\/\/doi.org\/10.1038\/s41586-018-0698-6.","journal-title":"Nature"},{"key":"673_CR28","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1126\/science.aaz8899","volume":"368","author":"LM Guthrie","year":"2020","unstructured":"Guthrie LM, Soma S, Yuan S, Silva A, Zulkifli M, Snavely TC, et al. Elesclomol alleviates Menkes pathology and mortality by escorting Cu to cuproenzymes in mice. Science. 2020;368:620\u20135. https:\/\/doi.org\/10.1126\/science.aaz8899.","journal-title":"Science"},{"key":"673_CR29","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 2005;102:15545\u201350. https:\/\/doi.org\/10.1073\/pnas.0506580102.","journal-title":"Proc Natl Acad Sci USA"},{"key":"673_CR30","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41568-021-00417-2","volume":"22","author":"EJ Ge","year":"2022","unstructured":"Ge EJ, Bush AI, Casini A, Cobine PA, Cross JR, DeNicola GM, et al. Connecting copper and cancer: from transition metal signalling to metalloplasia. Nat Rev Cancer. 2022;22:102\u201313. https:\/\/doi.org\/10.1038\/s41568-021-00417-2.","journal-title":"Nat Rev Cancer"},{"key":"673_CR31","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1002\/cncr.29692","volume":"122","author":"NF Esnaola","year":"2016","unstructured":"Esnaola NF, Meyer JE, Karachristos A, Maranki JL, Camp ER, Denlinger CS. Evaluation and management of intrahepatic and extrahepatic cholangiocarcinoma. Cancer. 2016;122:1349\u201369. https:\/\/doi.org\/10.1002\/cncr.29692.","journal-title":"Cancer"},{"key":"673_CR32","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.jhep.2019.11.020","volume":"72","author":"V Mazzaferro","year":"2020","unstructured":"Mazzaferro V, Gorgen A, Roayaie S, Droz Dit Busset M, Sapisochin G. Liver resection and transplantation for intrahepatic cholangiocarcinoma. J Hepatol. 2020;72:364\u201377. https:\/\/doi.org\/10.1016\/j.jhep.2019.11.020.","journal-title":"J Hepatol"},{"key":"673_CR33","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.canlet.2015.09.008","volume":"379","author":"H Zhang","year":"2016","unstructured":"Zhang H, Yang T, Wu M, Shen F. Intrahepatic cholangiocarcinoma: epidemiology, risk factors, diagnosis and surgical management. Cancer Lett. 2016;379:198\u2013205. https:\/\/doi.org\/10.1016\/j.canlet.2015.09.008.","journal-title":"Cancer Lett"},{"key":"673_CR34","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1039\/c0mt00006j","volume":"2","author":"S Lutsenko","year":"2010","unstructured":"Lutsenko S, Bhattacharjee A, Hubbard AL. Copper handling machinery of the brain. Metallomics. 2010;2:596\u2013608. https:\/\/doi.org\/10.1039\/c0mt00006j.","journal-title":"Metallomics"},{"key":"673_CR35","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1111\/j.1753-4887.2001.tb07017.x","volume":"59","author":"ED Harris","year":"2001","unstructured":"Harris ED. Copper homeostasis: the role of cellular transporters. Nutr Rev. 2001;59:281\u20135. https:\/\/doi.org\/10.1111\/j.1753-4887.2001.tb07017.x.","journal-title":"Nutr Rev"},{"key":"673_CR36","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1002\/hep.22261","volume":"47","author":"EA Roberts","year":"2008","unstructured":"Roberts EA, Schilsky ML, American Association for Study of Liver Diseases (AASLD). Diagnosis and treatment of Wilson disease: an update. Hepatology. 2008;47:2089\u2013111. https:\/\/doi.org\/10.1002\/hep.22261.","journal-title":"Hepatology"},{"key":"673_CR37","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1016\/j.molcel.2019.04.005","volume":"74","author":"X Tu","year":"2019","unstructured":"Tu X, Qin B, Zhang Y, Zhang C, Kahila M, Nowsheen S, et al. PD-L1 (B7-H1) competes with the RNA exosome to regulate the DNA damage response and can be targeted to sensitize to radiation or chemotherapy. Mol Cell. 2019;74:1215\u201326. https:\/\/doi.org\/10.1016\/j.molcel.2019.04.005.","journal-title":"Mol Cell"},{"key":"673_CR38","doi-asserted-by":"publisher","first-page":"2604","DOI":"10.1158\/0008-5472.CAN-18-3842","volume":"79","author":"D Cao","year":"2019","unstructured":"Cao D, Qi Z, Pang Y, Li H, Xie H, Wu J, et al. Retinoic acid-related orphan receptor C regulates proliferation, glycolysis, and chemoresistance via the PD-L1\/ITGB6\/STAT3 signaling axis in bladder cancer. Cancer Res. 2019;79:2604\u201318. https:\/\/doi.org\/10.1158\/0008-5472.CAN-18-3842.","journal-title":"Cancer Res"},{"key":"673_CR39","doi-asserted-by":"publisher","unstructured":"Li J, Xiao X, Ou Y, Cao L, Guo M, Qi C, et al. USP51\/PD-L1\/ITGB1-deployed juxtacrine interaction plays a cell-intrinsic role in promoting chemoresistant phenotypes in non-small cell lung cancer. Cancer Commun (Lond). 2023. https:\/\/doi.org\/10.1002\/cac2.12460.","DOI":"10.1002\/cac2.12460"},{"key":"673_CR40","doi-asserted-by":"publisher","first-page":"4164","DOI":"10.1038\/s41388-018-0252-x","volume":"37","author":"S Wang","year":"2018","unstructured":"Wang S, Li J, Xie J, Liu F, Duan Y, Wu Y, et al. Programmed death ligand 1 promotes lymph node metastasis and glucose metabolism in cervical cancer by activating integrin \u03b24\/SNAI1\/SIRT3 signaling pathway. Oncogene. 2018;37:4164\u201380. https:\/\/doi.org\/10.1038\/s41388-018-0252-x.","journal-title":"Oncogene"},{"key":"673_CR41","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.molcel.2019.09.030","volume":"76","author":"JH Cha","year":"2019","unstructured":"Cha JH, Chan LC, Li CW, Hsu JL, Hung MC. Mechanisms controlling PD-L1 expression in cancer. Mol Cell. 2019;76:359\u201370. https:\/\/doi.org\/10.1016\/j.molcel.2019.09.030.","journal-title":"Mol Cell"},{"key":"673_CR42","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1038\/s41556-020-0575-z","volume":"22","author":"J Hou","year":"2020","unstructured":"Hou J, Zhao R, Xia W, Chang CW, You Y, Hsu JM, et al. PD-L1-mediated gasdermin C expression switches apoptosis to pyroptosis in cancer cells and facilitates tumour necrosis. Nat Cell Biol. 2020;22:1264\u201375. https:\/\/doi.org\/10.1038\/s41556-020-0575-z.","journal-title":"Nat Cell Biol"},{"key":"673_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-021-01489-2","volume":"21","author":"M Yi","year":"2022","unstructured":"Yi M, Zheng X, Niu M, Zhu S, Ge H, Wu K. Combination strategies with PD-1\/PD-L1 blockade: current advances and future directions. Mol Cancer. 2022;21:28. https:\/\/doi.org\/10.1186\/s12943-021-01489-2.","journal-title":"Mol Cancer"},{"key":"673_CR44","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1001\/jamaoncol.2020.0930","volume":"6","author":"RD Kim","year":"2020","unstructured":"Kim RD, Chung V, Alese OB, El-Rayes BF, Li D, Al-Toubah TE, et al. A phase 2 multi-institutional study of nivolumab for patients with advanced refractory biliary tract cancer. JAMA Oncol. 2020;6:888\u201394. https:\/\/doi.org\/10.1001\/jamaoncol.2020.0930.","journal-title":"JAMA Oncol"},{"key":"673_CR45","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/S2468-1253(19)30086-X","volume":"4","author":"M Ueno","year":"2019","unstructured":"Ueno M, Ikeda M, Morizane C, Kobayashi S, Ohno I, Kondo S, et al. Nivolumab alone or in combination with cisplatin plus gemcitabine in Japanese patients with unresectable or recurrent biliary tract cancer: a non-randomised, multicentre, open-label, phase 1 study. Lancet Gastroenterol Hepatol. 2019;4:611\u201321. https:\/\/doi.org\/10.1016\/S2468-1253(19)30086-X.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"673_CR46","doi-asserted-by":"publisher","first-page":"e2212267.","DOI":"10.1002\/adma.202212267","volume":"35","author":"B Guo","year":"2023","unstructured":"Guo B, Yang F, Zhang L, Zhao Q, Wang W, Yin L, et al. Cuproptosis induced by ROS responsive nanoparticles with elesclomol and copper combined with \u03b1PD-L1 for enhanced cancer immunotherapy. Adv Mater. 2023;35:e2212267. https:\/\/doi.org\/10.1002\/adma.202212267.","journal-title":"Adv Mater"},{"key":"673_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-03883-4","volume":"21","author":"Y Zhou","year":"2023","unstructured":"Zhou Y, Xiao D, Jiang X, Nie C. EREG is the core onco-immunological biomarker of cuproptosis and mediates the cross-talk between VEGF and CD99 signaling in glioblastoma. J Transl Med. 2023;21:28. https:\/\/doi.org\/10.1186\/s12967-023-03883-4.","journal-title":"J Transl Med"},{"key":"673_CR48","doi-asserted-by":"publisher","first-page":"e2107771118.","DOI":"10.1073\/pnas.2107771118","volume":"118","author":"J Deng","year":"2021","unstructured":"Deng J, Yang H, Haak VM, Yang J, Kipper FC, Barksdale C, et al. Eicosanoid regulation of debris-stimulated metastasis. Proc Natl Acad Sci USA. 2021;118:e2107771118. https:\/\/doi.org\/10.1073\/pnas.2107771118.","journal-title":"Proc Natl Acad Sci USA"},{"key":"673_CR49","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s00262-021-02967-8","volume":"71","author":"L Liu","year":"2022","unstructured":"Liu L, Zhang R, Deng J, Dai X, Zhu X, Fu Q, et al. Construction of TME and Identification of crosstalk between malignant cells and macrophages by SPP1 in hepatocellular carcinoma. Cancer Immunol Immunother. 2022;71:121\u201336. https:\/\/doi.org\/10.1007\/s00262-021-02967-8.","journal-title":"Cancer Immunol Immunother"},{"key":"673_CR50","doi-asserted-by":"publisher","first-page":"147916412094567","DOI":"10.1177\/1479164120945675","volume":"17","author":"M Yasui-Kato","year":"2020","unstructured":"Yasui-Kato M, Patlada S, Yokode M, Kamei K, Minami M. EP4 signalling is essential for controlling islet inflammation by causing a shift in macrophage polarization in obesity\/type 2 diabetes. Diab Vasc Dis Res. 2020;17:1479164120945675. https:\/\/doi.org\/10.1177\/1479164120945675.","journal-title":"Diab Vasc Dis Res"},{"key":"673_CR51","doi-asserted-by":"publisher","first-page":"eabb7389.","DOI":"10.1126\/sciadv.abb7389","volume":"6","author":"X Wang","year":"2020","unstructured":"Wang X, Lin L, Lan B, Wang Y, Du L, Chen X, et al. IGF2R-initiated proton rechanneling dictates an anti-inflammatory property in macrophages. Sci Adv. 2020;6:eabb7389. https:\/\/doi.org\/10.1126\/sciadv.abb7389.","journal-title":"Sci Adv"}],"container-title":["Cancer Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41417-023-00673-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41417-023-00673-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41417-023-00673-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T00:04:39Z","timestamp":1702598679000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41417-023-00673-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,12]]},"references-count":51,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["673"],"URL":"https:\/\/doi.org\/10.1038\/s41417-023-00673-4","relation":{},"ISSN":["0929-1903","1476-5500"],"issn-type":[{"value":"0929-1903","type":"print"},{"value":"1476-5500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,12]]},"assertion":[{"value":"4 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study involving human participants was reviewed and approved by Ethics Committee in Clinical Research of Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University (NO. 20201231-46). The data used in this article are all items that must be checked according to medical standards during the hospitalization, and collected retrospectively when designing the study, without adding any additional medical examination or test outside the normal diagnosis and treatment procedures.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}]}}